Kalender
Tid* | ||
2026-02-11 | 07:30 | Bokslutskommuniké 2025 |
2025-10-24 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-18 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-04-28 | N/A | Årsstämma |
2025-04-28 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-11 | 07:30 | Bokslutskommuniké 2024 |
2024-10-25 | - | Kvartalsrapport 2024-Q3 |
2024-07-22 | - | Kvartalsrapport 2024-Q2 |
2024-05-10 | - | X-dag ordinarie utdelning BOUL 0.00 SEK |
2024-05-08 | - | Årsstämma |
2024-05-07 | - | Kvartalsrapport 2024-Q1 |
2024-02-06 | - | Bokslutskommuniké 2023 |
2023-11-09 | - | Kvartalsrapport 2023-Q3 |
2023-07-24 | - | Kvartalsrapport 2023-Q2 |
2023-05-05 | - | X-dag ordinarie utdelning BOUL 0.00 SEK |
2023-05-04 | - | Årsstämma |
2023-05-03 | - | Kvartalsrapport 2023-Q1 |
2023-02-02 | - | Bokslutskommuniké 2022 |
2022-11-10 | - | Kvartalsrapport 2022-Q3 |
2022-11-01 | - | Extra Bolagsstämma 2022 |
2022-07-18 | - | Kvartalsrapport 2022-Q2 |
2022-05-06 | - | X-dag ordinarie utdelning BOUL 0.55 SEK |
2022-05-05 | - | Årsstämma |
2022-05-04 | - | Kvartalsrapport 2022-Q1 |
2022-02-03 | - | Bokslutskommuniké 2021 |
2021-11-10 | - | Kvartalsrapport 2021-Q3 |
2021-07-19 | - | Kvartalsrapport 2021-Q2 |
2021-05-07 | - | X-dag ordinarie utdelning BOUL 0.55 SEK |
2021-05-06 | - | Årsstämma |
2021-05-06 | - | Kvartalsrapport 2021-Q1 |
2021-02-03 | - | Bokslutskommuniké 2020 |
2020-11-05 | - | Kvartalsrapport 2020-Q3 |
2020-07-17 | - | Kvartalsrapport 2020-Q2 |
2020-05-08 | - | X-dag ordinarie utdelning BOUL 0.00 SEK |
2020-05-07 | - | Årsstämma |
2020-05-07 | - | Kvartalsrapport 2020-Q1 |
2020-02-07 | - | Bokslutskommuniké 2019 |
2019-10-30 | - | Kvartalsrapport 2019-Q3 |
2019-08-14 | - | Kvartalsrapport 2019-Q2 |
2019-05-07 | - | X-dag ordinarie utdelning BOUL 0.55 SEK |
2019-05-06 | - | Årsstämma |
2019-05-06 | - | Kvartalsrapport 2019-Q1 |
2019-02-07 | - | Bokslutskommuniké 2018 |
2018-11-06 | - | Kvartalsrapport 2018-Q3 |
2018-08-15 | - | Kvartalsrapport 2018-Q2 |
2018-06-01 | - | Split BOUL 1:4 |
2018-05-15 | - | X-dag ordinarie utdelning BOUL 2.00 SEK |
2018-05-14 | - | Årsstämma |
2018-05-14 | - | Kvartalsrapport 2018-Q1 |
2018-02-16 | - | Bokslutskommuniké 2017 |
2017-11-08 | - | Kvartalsrapport 2017-Q3 |
2017-08-25 | - | Kvartalsrapport 2017-Q2 |
2017-05-12 | - | X-dag ordinarie utdelning BOUL 1.40 SEK |
2017-05-11 | - | Årsstämma |
2017-05-11 | - | Kvartalsrapport 2017-Q1 |
2017-02-16 | - | Bokslutskommuniké 2016 |
2016-11-09 | - | Kvartalsrapport 2016-Q3 |
2016-08-31 | - | Kvartalsrapport 2016-Q2 |
2016-05-13 | - | X-dag ordinarie utdelning BOUL 0.60 SEK |
2016-05-12 | - | Årsstämma |
2016-05-12 | - | Kvartalsrapport 2016-Q1 |
2016-02-18 | - | Bokslutskommuniké 2015 |
2015-11-04 | - | Kvartalsrapport 2015-Q3 |
2015-08-24 | - | Kvartalsrapport 2015-Q2 |
2015-05-13 | - | X-dag ordinarie utdelning BOUL 0.60 SEK |
2015-05-12 | - | Årsstämma |
2015-05-12 | - | Kvartalsrapport 2015-Q1 |
2015-02-13 | - | Bokslutskommuniké 2014 |
2014-11-05 | - | Kvartalsrapport 2014-Q3 |
2014-08-28 | - | Kvartalsrapport 2014-Q2 |
2014-05-14 | - | X-dag ordinarie utdelning BOUL 0.50 SEK |
2014-05-13 | - | Årsstämma |
2014-05-13 | - | Kvartalsrapport 2014-Q1 |
2014-02-07 | - | Bokslutskommuniké 2013 |
2013-10-30 | - | Kvartalsrapport 2013-Q3 |
2013-08-21 | - | Kvartalsrapport 2013-Q2 |
2013-04-24 | - | X-dag ordinarie utdelning BOUL 0.50 SEK |
2013-04-23 | - | Årsstämma |
2013-04-23 | - | Kvartalsrapport 2013-Q1 |
2013-03-13 | - | 15-7 2013 |
2013-02-19 | - | Bokslutskommuniké 2012 |
2012-11-09 | - | Kvartalsrapport 2012-Q3 |
2012-08-30 | - | Kvartalsrapport 2012-Q2 |
2012-06-14 | - | Kapitalmarknadsdag 2012 |
2012-05-04 | - | X-dag ordinarie utdelning BOUL 0.00 SEK |
2012-05-03 | - | Årsstämma |
2012-04-26 | - | Kvartalsrapport 2012-Q1 |
2012-02-21 | - | Bokslutskommuniké 2011 |
2011-11-29 | - | 15-7 2011 |
2011-11-11 | - | Kvartalsrapport 2011-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
As previously announced, Torben Nielsen is appointed new President and CEO of Boule Diagnostics AB. He will assume the position as of 16 April 2024, succeeding Jesper Söderqvist who at the same time leaves Boule Diagnostics AB.
Torben Nielsen most recently held the position as Executive Vice President in the Analytical Solutions and Customer Enablement business area at PerkinElmer. He brings extensive experience from the hematology market, having worked at Radiometer from 2005 to 2019. His roles included General Manager for Radiometer America and previously Sales Manager for Western Europe. Nielsen also has broader experience in the medical technology industry, having served as Sales Manager for EMEA in the subsidiary companies Ormco and Spark within the Envista group.
For more information, please contact:
Torben Jörgensen, Chairman of Boule Diagnostics AB, torben.jorgensen@biotage.com
Holger Lembrér, CFO, Boule Diagnostics AB, phone: +46 (0)72-230 77 10, holger.lembrer@boule.com
About Boule Diagnostics AB (publ)
Boule Diagnostics AB (publ) is a global diagnostics company specializing in near-patient, decentralized blood diagnostics and one of the few companies in the global diagnostics market that conducts its own development, manufacturing and marketing of instruments and consumables for blood diagnostics. The Company primarily serves hospitals, clinics, laboratories and other diagnostics companies to which it offers complete systems for blood diagnostics (hematology) in both the human and veterinary areas. Boule has strong positions in important emerging markets such as in Asia and in recent years has improved its position in the fast-growing veterinary market. Operations are conducted through operating subsidiaries in Sweden, the United States, Mexico and Russia. The Group reported net sales of SEK 571 million in 2023 and has more than 200 employees. Sales are conducted globally, predominantly through the company’s 200 or so distributors in over 100 countries, supported by Boule’s own local sales and service personnel. Boule has been listed on Nasdaq Stockholm since 2011. www.boule.com